Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD

Blood (2018) 132 (Supplement 1): 786.

https://doi.org/10.1182/blood-2018-99-110240

Published: 2018

Journal Articles

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Marcel Nijland, MD, Karin Boslooper, MD, Anke Van den Berg, PhD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Joosten, MD, Huib Storm, MD PhD, Robby Kibbelaar, MD PhD, Gustaaf van Imhoff, MD PhD, Mels Hoogendoorn, MD PhD

Blood (2015) 126 (23): 1503.

https://doi.org/10.1182/blood.V126.23.1503.1503

Published: 2015

Journal Articles

DMSO Reduction Strategies Reduce DMSO Induced Post Autologous Transplant Morbidity In Patients with Lymphoma and Myeloma –Results from an EBMT Non Interventional Prospective Study

Curly TCM Morris, Marijke Scholten, Liesbeth de Wreede, Anja van Biezen, Ebbe Dickmeiss, Marek Trneny, Jane F. Apperley, Patrizia Chiusolo, Gustaaf Van Imhoff, MD, PhD, Stig Lenhoff, MD, PhD, Lutz Uharek, Giovanni Martinelli, MD, Marcus Hentrich, MD, Anna Sureda, MD, PhD, Theo M de Witte, Tapani Ruutu, MD

Blood (2010) 116 (21): 2397.

https://doi.org/10.1182/blood.V116.21.2397.2397

Published: 2010

Journal Articles

Acute Painful Radiculopathy After Intrathecal Rituximab

Jacoline Bromberg, Jeanette Doorduyn, Johanna W. Baars, MD, PhD, Gustaaf Van Imhoff, MD, PhD, Roelien Enting, Martin van den Bent

Blood (2010) 116 (21): 4920.

https://doi.org/10.1182/blood.V116.21.4920.4920

Published: 2010

Journal Articles

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Chuanhui Xu, Anke Van Den Berg, PhD, Wouter Plattel, drs., Nele Ruther, Huang Xin, Sr, Miao Wang, Gustaaf Van Imhoff, MD, PhD, Andreas Viardot, Peter Möller, Sibrand Poppema, MD, PhD, Lydia Visser, PhD

Blood (2010) 116 (21): 3880.

https://doi.org/10.1182/blood.V116.21.3880.3880

Published: 2010

Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2010) 116 (21): 748.

https://doi.org/10.1182/blood.V116.21.748.748

Published: 2010

Journal Articles

Comorbidity at Relapse Is An Independent Predictor for Eligibility and Outcome of Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma.

Wouter J Plattel, MD, Hanneke C Kluin-Nelemans, MD, PhD, Geertruida H de Bock, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2009) 114 (22): 2313.

https://doi.org/10.1182/blood.V114.22.2313.2313

Published: 2009

Journal Articles

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

Arjan Diepstra, MD, PhD, Anne Marijn van der Graaf, Hans JTWM Vos, Lydia Visser, PhD, Anke Van Den Berg, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2009) 114 (22): 3663.

https://doi.org/10.1182/blood.V114.22.3663.3663

Published: 2009

Journal Articles

Polymorphisms and Lack of or Aberrant Expression of HLA Class I and II May Influence Antigen Presentation in Classical Hodgkin Lymphoma.

Arjan Diepstra, MD, Sibrand Poppema, MD, PhD, Gerard te Meerman, PhD, Marijke Niens, MSc, Ilja Nolte, MSc, PhD, Edo Vellenga, MD, PhD, Gustaaf van Imhoff, MD, Joost Kluiver, MSc, Anke van den Berg, MSc, PhD

Blood (2005) 106 (11): 20.

https://doi.org/10.1182/blood.V106.11.20.20

Published: 2005

Journal Articles

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Eugenia Haralambieva, Evert-jan Boerma, Gustaaf van Imhoff, MD, Stefano Rosati, MD, Ed Schuuring, PhD, Hans-Konrad Mueller-Hermelink, MD PhD, Philip M. Kluin, MD PhD, German Ott, MD PhD

Blood (2004) 104 (11): 2275.

https://doi.org/10.1182/blood.V104.11.2275.2275

Published: 2004

Journal Articles

Pre-Transplantation FDG-PET Is the Best Predictor for Outcome in Relapsed Lymphoma Patients Treated with Autologous Stem Cell Transplantation.

Bart Schot, MD, Wim Sluiter, PhD, Gustaaf van Imhoff, MD, Jan Pruim, PhD, Miryam de Brouwer, Carolien Verhoogt, Wim Vaalburg, PhD, Edo Vellenga, PhD.

Blood (2004) 104 (11): 3260.

https://doi.org/10.1182/blood.V104.11.3260.3260

Published: 2004

NARROW

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

DMSO Reduction Strategies Reduce DMSO Induced Post Autologous Transplant Morbidity In Patients with Lymphoma and Myeloma –Results from an EBMT Non Interventional Prospective Study

Acute Painful Radiculopathy After Intrathecal Rituximab

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Comorbidity at Relapse Is An Independent Predictor for Eligibility and Outcome of Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma.

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

Polymorphisms and Lack of or Aberrant Expression of HLA Class I and II May Influence Antigen Presentation in Classical Hodgkin Lymphoma.

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Pre-Transplantation FDG-PET Is the Best Predictor for Outcome in Relapsed Lymphoma Patients Treated with Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only